Dr. Reddy’s Laboratories launches eye drops for post-surgery care in United States

Dr. Reddy’s Laboratories Ltd. on Friday announced that it has launched Difluprednate Ophthalmic Emulsion 0.05%.

This medication is used to treat swelling and pain after eye surgery. It may also be used to treat a certain serious eye problem. This medication belongs to a class of drugs known as corticosteroids.

According to Dr. Reddy’s Labs, it is a therapeutic generic equivalent to Durezol (Difluprednate Ophthalmic Emulsion 0.05%) in the U.S. market, following the approval by the U.S. Food and Drug Administration (USFDA).

Also Read

USFDA gives final nod to Alembic Pharmaceuticals’ Glaucoma drug

Sanofi receives marketing approval for its diabetes drug in India

18 Pharmaceutical companies lose their license over poor quality medicines; Here are the details

Dr. Reddy’s focuses on differentiated portfolio in key therapy areas as part of India growth strategy: GlobalData

The Durezol brand and generic had U.S. sales of approximately $40 million MAT for the most recent twelve months ending in Nov 2022 according to IQVIA.

Dr. Reddy’s Difluprednate Ophthalmic Emulsion 0.05% is available in 5 ml bottles in case packs of 24.